Monopar Therapeutics (MNPR) Cash & Equivalents Growth (5y) (2021 - 2025)
Monopar Therapeutics (MNPR) Cash & Equivalents Growth (5y) (2021 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Monopar Therapeutics | 800.03 Mn | 738.20 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 30.07% |
| Sep 30, 2025 | 48.00% |
| Jun 30, 2025 | 25.78% |
| Mar 31, 2025 | 25.82% |
| Dec 31, 2024 | 28.23% |
| Sep 30, 2024 | 6.02% |
| Jun 30, 2024 | 3.59% |
| Mar 31, 2024 | 5.83% |
| Dec 31, 2023 | 1.06% |
| Sep 30, 2023 | -6.26% |
| Jun 30, 2023 | -2.57% |
| Mar 31, 2023 | 3.04% |
| Dec 31, 2022 | -3.50% |
| Sep 30, 2022 | 5.63% |
| Jun 30, 2022 | 30.91% |
| Mar 31, 2022 | 38.07% |
| Dec 31, 2021 | 47.43% |